JF
VIR icon

Jump Financial’s Vir Biotechnology VIR Stock Holding History

Jump Financial’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.67M Buy
458,671
+336,605
+276% +$3.2M 0.04% 551
2026
Q1 		$1.09M Buy
+122,066
New +$973K 0.01% 887
2024
Q4 		– Sell
-32,862
Closed -$246K – 2047
2024
Q3 		$246K Sell
32,862
-82,821
-72% -$719K 0.01% 1385
2024
Q2 		$1.03M Buy
115,683
+35,775
+45% +$343K 0.02% 802
2024
Q1 		$809K Buy
+79,908
New +$814K 0.02% 914
2023
Q4 		– Sell
-50,263
Closed -$471K – 2289
2023
Q3 		$471K Buy
50,263
+36,192
+257% +$516K 0.02% 1051
2023
Q2 		$345K Sell
14,071
-86,382
-86% -$2.17M 0.01% 1237
2023
Q1 		$2.34M Buy
100,453
+60,162
+149% +$1.54M 0.1% 323
2022
Q4 		$1.02M Buy
40,291
+23,491
+140% +$576K 0.05% 474
2022
Q3 		$324K Buy
+16,800
New +$427K 0.01% 1107
2022
Q2 		– Sell
-24,414
Closed -$628K – 2047
2022
Q1 		$628K Buy
+24,414
New +$724K 0.03% 709
2021
Q3 		– Sell
-36,951
Closed -$1.75M – 1528
2021
Q2 		$1.75M Sell
36,951
-349
-0.9% -$15.9K 0.17% 140
2021
Q1 		$1.91M Buy
37,300
+8,351
+29% +$450K 0.18% 109
2020
Q4 		$775K Buy
+28,949
New +$941K 0.13% 228

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jump Financial's VIR Position: Q2 2026 in Review

Jump Financial increased its Vir Biotechnology (VIR) stake by 276% in Q2 2026, buying an estimated $3.2M and bringing the position to 458,671 shares worth $4.67M. The position accounts for 0.04% of the portfolio, ranked #551.

Jump Financial first reported a position in VIR in Q4 2020 and has held it in 14 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Jump Financial held 458,671 shares of Vir Biotechnology worth $4.67M as of Q2 2026.
  • Jump Financial bought 336,605 Vir Biotechnology shares in Q2 2026, an estimated $3.2M.
  • Vir Biotechnology made up 0.04% of Jump Financial's portfolio in Q2 2026, its #551 holding.
  • Jump Financial first reported a position in Vir Biotechnology in Q4 2020 and has held it in 14 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.